‘THE REAL HOUSEWIVES OF NEW JERSEY’ ORIGINAL CAST MEMBER JACQUELINE LAURITA REVEALS ARTEFILL® AS HER BEAUTY SECRET

Lasting Dermal Filler for Wrinkle Correction Gives Laurita a Refreshed Look

SAN DIEGO, Calif., Feb. 12, 2014  Jacqueline Laurita, original cast member of The Real Housewives of New Jersey, revealed that she relies on ArteFill® Injectable Wrinkle Filler as one of her beauty secrets.

“Having tried a few different temporary fillers in the past, I’m very happy to have found ArteFill®, as it gives me the natural, lasting results I desire,” said Laurita. “Being in the spotlight, I am always looking for the newest and greatest skin care treatments and am thrilled with ArteFill®’s effectiveness.”

ArteFill® is a dermal filler that is FDA approved for the correction of nasolabial folds commonly known as “smile lines.”

“ArteFill® has been a remarkable addition to my practice, as my patients have been very pleased with the results and have seen wonderful improvements in the look and feel of their skin,” said Laurita’s physician, Dr. William Song of Omni Medical Laser Skin Care. “ArteFill® offers me the ability to fine tune and shape patients’ features, giving them the exact look that they’re going for and the confidence they’ve always wanted.”

ArteFill® is manufactured and distributed by Suneva Medical, Inc.

To learn more about ArteFill®, visit www.artefill.com or follow on Facebook: https://www.facebook.com/Artefill.

About Suneva Medical, Inc.
Suneva Medical, Inc. is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the general dermatology and aesthetic markets. The company currently markets ArteFill® in the U.S., Korea and Singapore; ReFissa® and Regenica® Skincare in the U.S. and Bellafill® in Canada. For more information, visit www.sunevamedical.com/old. 

Ms. Laurita’s comments do not imply any endorsement by NBC Universal or any parent, subsidiary or affiliated company.

Multimedia Assets associated with this release:  
Video: http://origin-qps.onstreammedia.com/origin/multivu_archive/PRNA/ENR/FX-LA63262-20140211-1.mp4

Important Safety Information

Bellafill®
Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. Patients who have had a positive reaction to the Bellafill® Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring should not receive Bellafill®. The safety of Bellafill® for use during pregnancy, breastfeeding, or in patients under 21 has not been established. You may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1–7 days. You may experience lumps/bumps/papules that may occur more than one month after injection and that may persist. Less common side effects include rash and itching more than 48 hours after treatment, persistent swelling or redness, lumps/bumps, acne, and increased sensitivity at treatment sites. Infrequently, granulomas may occur and may be treated by your licensed physician provider. Be sure to call your licensed provider immediately if you notice any unusual skin reactions around the treatment area. Based on the 5-year Post-Approval Study on nasolabial folds with 1,008 patients, long-term safety of Bellafill® for up to 5 years has been established.

PUREGRAFT
This product is certified as a medical device in the European Union under the Medical Device Directive 93/42/EEC by SGS CE0120, exclusively for the indication of autologous fat transfer. Other non-medical uses ascribed to this device such as aesthetic body contouring are not within the scope of CE certification, and users should be aware product performance and/or safety has not been evaluated by SGS for those purposes.

Suneva Medical HD PRP
REGULATORY STATUS: FDA-cleared 510(k) Class II medical device. Healeon HD PRP is designed to be used for the safe and rapid preparation of autologous platelet-rich-plasma (PRP) from a small sample of peripheral blood at the patient point of care. The PRP is mixed with autograft and/orallograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK170136

Silhouette Instalift
Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.

IMPORTANT SAFETY CONSIDERATIONS
The Silhouette InstaLift device should not be used in patients with any known allergy or foreign body sensitivities to plastic/ biomaterial or in situations where internal fixation is otherwise contraindicated, (e.g. infection.) The device should also not be used in patients appearing to have very thin soft tissue of the face in which the implant may be visible or palpable.

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction, pain (which may be temporary or persistent in nature), swelling and edema, transient hematoma or bruising and transient rippling or dimple formation. For further safety or product information, please consult your physician.

For more safety information, please consult with your physician and the patient labeling that can be found by visiting our website www.bellafill.com.
Toll-free call (U.S. & Canada): 844-Bellafill (844-235-5234).
Local calls: 858-550-9999. International calls: ++ 858-550-9999.